Fund profile
Tickers
HELX
Fund manager
Total assets
$10.68 mm
Liabilities
$4.61 k
Net assets
$10.67 mm
Number of holdings
59.00
59 Holdings
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
MEDP Medpace Holdings Inc | 693.37 k | 2.26 k shares | 6.50 | Common equity | Long | USA |
TMO Thermo Fisher Scientific Inc. | 650.22 k | 1.23 k shares | 6.09 | Common equity | Long | USA |
DHR Danaher Corp. | 561.46 k | 2.43 k shares | 5.26 | Common equity | Long | USA |
VRTX Vertex Pharmaceuticals, Inc. | 515.94 k | 1.27 k shares | 4.83 | Common equity | Long | USA |
REGN Regeneron Pharmaceuticals, Inc. | 471.64 k | 537.00 shares | 4.42 | Common equity | Long | USA |
LLY Lilly(Eli) & Co | 355.58 k | 610.00 shares | 3.33 | Common equity | Long | USA |
Sartorius AG | 343.78 k | 934.00 shares | 3.22 | Preferred equity | Long | Germany |
IONS Ionis Pharmaceuticals Inc | 341.28 k | 6.75 k shares | 3.20 | Common equity | Long | USA |
Samsung Biologics Co Ltd
|
336.36 k | 570.00 shares | 3.15 | Common equity | Long | Korea, Republic of |
KRYS Krystal Biotech Inc | 315.61 k | 2.54 k shares | 2.96 | Common equity | Long | USA |
BRKR Bruker Corp | 306.56 k | 4.17 k shares | 2.87 | Common equity | Long | USA |
CRL Charles River Laboratories International Inc. | 262.64 k | 1.11 k shares | 2.46 | Common equity | Long | USA |
AstraZeneca PLC
|
260.38 k | 3.87 k shares | 2.44 | Common equity | Long | UK |
BNTX BioNTech SE | 249.39 k | 2.36 k shares | 2.34 | Common equity | Long | Germany |
A Agilent Technologies Inc. | 236.91 k | 1.70 k shares | 2.22 | Common equity | Long | USA |
CDNS Cadence Design Systems, Inc. | 230.43 k | 846.00 shares | 2.16 | Common equity | Long | USA |
ALNY Alnylam Pharmaceuticals Inc | 224.72 k | 1.17 k shares | 2.11 | Common equity | Long | USA |
QIAGEN NV
|
218.80 k | 5.04 k shares | 2.05 | Common equity | Long | Netherlands |
CTVA Corteva Inc | 207.40 k | 4.33 k shares | 1.94 | Common equity | Long | USA |
MRNA Moderna Inc | 205.86 k | 2.07 k shares | 1.93 | Common equity | Long | USA |
Lonza Group AG
|
183.23 k | 436.00 shares | 1.72 | Common equity | Long | Switzerland |
EXAS Exact Sciences Corp. | 179.03 k | 2.42 k shares | 1.68 | Common equity | Long | USA |
SDGR Schrodinger Inc | 176.57 k | 4.93 k shares | 1.65 | Common equity | Long | USA |
NTLA Intellia Therapeutics Inc | 162.02 k | 5.31 k shares | 1.52 | Common equity | Long | USA |
ICON PLC
|
155.12 k | 548.00 shares | 1.45 | Common equity | Long | Ireland |
RVTY Revvity Inc. | 153.25 k | 1.40 k shares | 1.44 | Common equity | Long | USA |
RCKT Rocket Pharmaceuticals Inc | 147.27 k | 4.91 k shares | 1.38 | Common equity | Long | USA |
IQV IQVIA Holdings Inc | 125.64 k | 543.00 shares | 1.18 | Common equity | Long | USA |
Evotec SE
|
125.25 k | 5.33 k shares | 1.17 | Common equity | Long | Germany |
RGEN Repligen Corp. | 118.49 k | 659.00 shares | 1.11 | Common equity | Long | USA |
LH Laboratory Corp. Of America Holdings | 115.46 k | 508.00 shares | 1.08 | Common equity | Long | USA |
TECH Bio-Techne Corp | 112.65 k | 1.46 k shares | 1.06 | Common equity | Long | USA |
DVAX Dynavax Technologies Corp. | 109.60 k | 7.84 k shares | 1.03 | Common equity | Long | USA |
SRPT Sarepta Therapeutics Inc | 105.78 k | 1.10 k shares | 0.99 | Common equity | Long | USA |
Oxford Nanopore Technologies PLC
|
88.47 k | 33.33 k shares | 0.83 | Common equity | Long | UK |
BMY Bristol-Myers Squibb Co. | 82.61 k | 1.61 k shares | 0.77 | Common equity | Long | USA |
CDMO Avid Bioservices Inc | 80.38 k | 12.37 k shares | 0.75 | Common equity | Long | USA |
GH Guardant Health Inc | 78.88 k | 2.92 k shares | 0.74 | Common equity | Long | USA |
BIO Bio-Rad Laboratories Inc. - Ordinary Shares | 77.17 k | 239.00 shares | 0.72 | Common equity | Long | USA |
CRISPR Therapeutics AG
|
71.05 k | 1.14 k shares | 0.67 | Common equity | Long | Switzerland |
LGND Ligand Pharmaceuticals, Inc. - Ordinary Shares | 67.06 k | 939.00 shares | 0.63 | Common equity | Long | USA |
NTRA Natera Inc | 64.58 k | 1.03 k shares | 0.61 | Common equity | Long | USA |
AZTA Azenta Inc | 63.90 k | 981.00 shares | 0.60 | Common equity | Long | USA |
FDMT 4D Molecular Therapeutics Inc | 63.66 k | 3.14 k shares | 0.60 | Common equity | Long | USA |
PRVA Privia Health Group Inc | 61.90 k | 2.69 k shares | 0.58 | Common equity | Long | USA |
BEAM Beam Therapeutics Inc | 54.60 k | 2.01 k shares | 0.51 | Common equity | Long | USA |
TWST Twist Bioscience Corp | 53.41 k | 1.45 k shares | 0.50 | Common equity | Long | USA |
Bavarian Nordic A/S
|
46.67 k | 1.78 k shares | 0.44 | Common equity | Long | Denmark |
SLP Simulations Plus Inc. | 44.93 k | 1.00 k shares | 0.42 | Common equity | Long | USA |
ARE Alexandria Real Estate Equities Inc. | 35.75 k | 282.00 shares | 0.33 | Common equity | Long | USA |
DOCS Doximity Inc - Ordinary Shares | 34.83 k | 1.24 k shares | 0.33 | Common equity | Long | USA |
AVTR Avantor Inc. | 27.60 k | 1.21 k shares | 0.26 | Common equity | Long | USA |
CFRXQ CONTRAFECT Corp | 26.60 k | 2.71 k shares | 0.25 | Common equity | Long | USA |
TXG 10x Genomics Inc - Ordinary Shares | 22.33 k | 399.00 shares | 0.21 | Common equity | Long | USA |
VCYT Veracyte Inc | 22.04 k | 801.00 shares | 0.21 | Common equity | Long | USA |
FTRE Fortrea Holdings Inc | 17.73 k | 508.00 shares | 0.17 | Common equity | Long | USA |
OLK Olink Holding AB (publ) | 14.08 k | 560.00 shares | 0.13 | Common equity | Long | Sweden |
OABI OmniAb Inc | 0 | 240.00 shares | 0.00 | Common equity | Long | USA |
OABI OmniAb Inc | 0 | 240.00 shares | 0.00 | Common equity | Long | USA |